Loading...
7th Antibody Industrial Symposium 2019 - Harnessing the Immune System with therapeutic antibodies June 24 - 25 2019 / Tours | France
News Twitter

Programme

schedule & speakers

Day 1

Monday, 24th June 2019

8h30

Registration & welcome coffee

9h15

Welcome address

9h30

Session I – Harnessing the Immune System with Immunomodulatory therapeutic Antibodies

Keynote Lecture

Stéphanie Cornen

Stéphanie Cornen
Director, Target Discovery
Innate Pharma, France
NK cells as target for therapeutic intervention

Raphaëlle GILLET, Ph.D

Raphaëlle GILLET, Ph.D
European & French Patent Attorney
REGIMBEAU, France

Nicolas BOUQUIN, Ph.D

Nicolas BOUQUIN, Ph.D
Senior Associate, European & French Patent Attorney
REGIMBEAU, France

An IP overview on immunotherapy

10h30

Coffee Break – Networking – Partnering (B2B meetings) - Poster Session

11h00

Session II – Immunomodulation via cell membrane antigens – part 1

Nicolas Poirier

Nicolas Poirier
Chief Scientific Officer
OSE Immunotherapeutics, France
Selective anti-SIRPα antibody : Next generation Myeloid Checkpoint Inhibitor

Lucia Pattarini

Lucia Pattarini
Project Manager Immuno-Oncology
SERVIER, France

12h00

Lunch – Networking – Partnering (B2B) - Poster Session

14h00

Session II – Immunomodulation via cell membrane antigens – part 2

Prof. David-Axel Laplaud

Prof. David-Axel Laplaud
Professor & Physician
University of Nantes, Faculty of Medicine, France
title available soon

Daniel Olive

Daniel Olive
Professor
Aix Marseille University Institut Paoli Calmettes
Co-founder
Imcheck Therapeutics

15h00

Keynote Lecture

Mathias Chamaillard

Mathias Chamaillard
Professor, Research Director
Institut Pasteur de Lille Center for Infection & Immunity of Lille

15h30

Coffee Break – Networking – Partnering (B2B) - Poster Session

16h00

Session III – Pitch presentations : Immunomodulation with therapeutic antibodies – new strategies & technologies

18h30

End of day 1

20h00

Cocktail Dinner – Château Belmont

Day 2

Tuesday, 25th June 2019

8h30

Welcome coffee

9h00

Keynote Lecture

Brendan O’Callaghan

Brendan O’Callaghan
SVP & Global Head Biologics Platform
SANOFI, Germany

9h45

Session IV – Immunomodulation via Soluble Antigens – part 1

Annemarie Van Nieuwenhuijze

Annemarie Van Nieuwenhuijze
Senior Scientist
Ablynx, Belgium
The use of Nanobodies as therapeutics for immuno-oncology

Anne Tsicopoulos

Anne Tsicopoulos
Team Leader Pulmonary immunity
Center for Infection & Immunity of Lille (CIIL), France
title available soon

10h45

Coffee Break – Networking – Partnering (B2B) - Poster Session

11h15

Session IV – Immunomodulation via Soluble Antigens – part 2

Justyna Ogonek

Justyna Ogonek
Postdoctoral Researcher, Division of Clinical Pharmacology
Ludwig-Maximilians University Hospital Munich, Germany
High affinity CD16-polymorphism and Fc-engineered antibodies enhance activity of anti-CD16-CAR T cells for cancer therapy

12h15

Lunch – Networking – Partnering (B2B) - Poster Session

14h30

Session V – Immunomodulation via FC – FcyR interactions

Alain Beck

Alain Beck
Senior Director, Biologics CMC & developability
Pierre Fabre laboratories, France
Associate Editor
Journal mAbs, USA
Fc-mediated functions modulation: options, structure assessment and developability

Marie Godar

Marie Godar
Scientist
ArgenX, Belgium
Efgartigimod, a novel FcRn antagonist, for the treatment of patients with severe autoimmune diseases

Mireia Pelegrin

Mireia Pelegrin
Project Leader
Institute of Molecular Genetics of Montpellier, France
Vaccine-like Effects of Antiviral Monoclonal Antibodies: Converting Immunotherapies from Passive to Active

Fabian Käsermann

Fabian Käsermann
Head Preclinical Innovation, Assoc Dir Research, R&D
CSL Behring AG, Switzerland
Recombinant Fc multimers — potential next generation biologics for autoimmune inflammatory disorders

16h30

Prize Best Pitch & Poster

16h45

Closing remarks – Announcement AIS2020

17h00

End of Symposium

Organization contact
Ana Antunes
17 rue Crépet
69007 Lyon
+33 (0)4 78 02 39 91
ana-sofia.antunes@mabdesign.fr